We use cookies on our site to track usage and preferences. Learn more

Biofidelity announces first peer reviewed publication of breakthrough ASPYRE technology

  • Date 29 Mar 2021

Biofidelity Ltd, the cancer diagnostics company, today announces that the first peer review article detailing its novel ASPYRE technology has been published in Scientific Reports, a Nature journal.  The article, titled "Single-copy detection of somatic variants from solid and liquid biopsy" is freely available online at www.nature.com/articles/s41598-021-85545-3.

As well as detailing the novel technology behind ASPYRE, the publication evidences the flexibility of Biofidelity’s breakthrough approach, through its application to the detection of a variety of key genetic mutations used to guide treatment decisions in lung cancer.

Read more

Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs

Read more